FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO...

25
ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical Device Industry Coalition ISO 14971: Overview of the standard Risk Management Through Product Life Cycle: An Educational Forum William A. Hyman Department of Biomedical Engineering Texas A&M University April 2010 2 Medical devices – Application of risk management to medical devices - 14 pages in body - 63 pages in 10 Annexes

Transcript of FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO...

Page 1: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 1

FDA Medical Device Industry Coalition

ISO 14971: Overview of the standard

Risk Management Through Product Life Cycle: An Educational Forum

William A. HymanDepartment of Biomedical EngineeringTexas A&M University

April 2010 2

Medical devices –Application of risk management to medical devices

- 14 pages in body- 63 pages in 10 Annexes

Page 2: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 2

ContentsScopeTerms and definitionsGeneral requirementsRisk analysisRisk evaluationRisk controlResidual risk acceptabilityReport/documentationPost-production

April 2010 3

ContentsScopeTerms and definitionsGeneral requirementsRisk analysisRisk evaluationRisk controlResidual risk acceptabilityReport/documentationPost-production

April 2010 4

Page 3: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 3

AnnexesRationaleOverviewIdentifying device characteristics that have riskRisk conceptsExamples of hazardsRisk management planTechniquesIn vitro Biological hazardsResidual risk

April 2010 5

April 2010

Observations on 14971

It is “voluntary”It is cited and recognized by FDA

A search within FDA for ISO 14971 produces 564 items!

It’s useful application requires knowledge and diligence

Page 4: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 4

April 2010

Observations on 14971

The reasons to undertake risk management (guided by 14971) are that:

Reducing risk is a good thingCompliance is also a good thing

Don’t let the compliance imperative overwhelm the risk control imperative

Direct citations of 14971 in submitted documents

From an MDR: …risk analysis (performed according to ISO 14971 2000…

From a 510(k) Summary: …risk analysis preformed identified…by ISO 14971and QSR and internal procedures for risk analysis.

April 2010 8

Page 5: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 5

General principles

Risk is commonly described as having two principle components:

> Severityif the harm occurs

> Probabilityof the harm occurring

April 2010 9

A few definitions

Harm is the adverse eventHazard is the potential cause of the harm

Note: You can detect a hazard before it causes harm, but detecting harm means the harm already occurred

Safety is the absence of unacceptable risksBut unacceptable to whom?

April 2010 10

Page 6: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 6

General principles

Risk management is something that you have to

actively do

It is not simply a byproduct of general good intentions and good engineering

April 2010 11

General principles

Risk can often not be reduced to zero…but this is not an excuse for all hazards and harmsThere may be “residual risks” after appropriate risk evaluation and controlResidual risks must undergo acceptance and communication activities

12

Page 7: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 7

The process – part 1

April 2010 13

Risk Analysis

Risk Evaluation

Risk Control

Risk

Assessment

The process – part 1

April 2010 14

Risk Analysis

Risk Evaluation

Risk Control

Risk

Assessment

Cycle!

Page 8: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 8

The process – part 2

15

Risk Analysis

Risk Evaluation

Risk ControlCycle!

Acceptability?

The process – part 3

16

Risk Analysis

Risk Evaluation

Risk Control Risk

Management

Cycle!

Acceptability?

Report

Post Production

Page 9: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 9

A note on post production

Manufacturing deviationsComplaints and complaint handlingCAPARecalls

April 2010 17

Capture

Evaluate

Act

Evaluate

General requirements in 14971(Section 3)

A formal (documented) process and plan in placeManagement commitment

ResourcesPersonnel

Qualified personnelDocumented results

April 2010 18

Page 10: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 10

Risk analysis (Section 4)

Intended use and misuseRisk related characteristicsHazard identification

> known and foreseeable

Risk estimation> systematic> based on available and general

informationApril 2010 19

Risk evaluation (Section 5)

Manufacturer determined criteria for

Risk acceptability decision making

There is not a predetermined, all purposeacceptable level of risk

> no equation> no regulation

April 2010 20

Page 11: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 11

Risk control (Section 6) - Engineering

Elimination by (re)designProtective measures to protect against the risk – both physical and alarmsInformation (IFUs, training)

April 2010 21

Preferably in this order!

You shouldn’t try to fix a dangerous design with a warning (if you could have reasonably designed it out)!

Risk control (Section 6) -Management

Residual risk evaluation after controls are applied Another round of acceptance decision making including

Risk/benefit analysis (Section 6.5)> an effort to make otherwise

unacceptable risks acceptable –which is potentially confusing

If accepted --- disclosure decision making

April 2010

Page 12: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 12

Overall risk (Section 7) - Management

After all individual risk control activity has been done…then decision making applied to complete design

Note: assessing the collective risk that results from the individual risks is a challenging and imprecise procedure

April 2010 23

Report (Section 8)

Review pre product releaseAppropriately implementedOverall residual risk is acceptablePost production processes are in place

Documented

April 2010 24

Page 13: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 13

Post production(Section 9)

Collect and reviewAttention to previously unrecognized risksAttention to severity or rate of occurrence above originally estimatedInclude feedback into risk management process itself

April 2010 25

AnnexesRationaleOverviewIdentifying device characteristics associated with riskRisk conceptsExamples of hazardsRisk management planTechniquesIn vitro Biological hazardsResidual risk

26

Page 14: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 14

Annex C – Questions -examplesIntended and means of use (& user)Materials and componentsSterile, or user sterilizationMeasurements and data interpretationUse in conjunction with…

interfacingUnwanted outputs (e.g. Noise, heat, EMI)Susceptible to environment, forces, etc.

27

Annex C – Questions (cont)

Software (& menus)Reuse, intended and single useInstallation & use trainingNew manufacturing processesTransmittal of user informationUser interface issues – human factors

distractionsalarmspredictable misuse

28

Page 15: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 15

Note

Lists of questions, lists of hazards, check lists, pull down menus, etc are not a substitute for thoughtful analysis by a knowledgeable person

The more unique/different your device is, the less likely it is that pre-prepared lists will be comprehensive

April 2010 29

AnnexesRationaleOverviewIdentifying device characteristics associated with riskRisk conceptsExamples of hazardsRisk management planTechniquesIn vitro Biological hazardsResidual risk

30

Page 16: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 16

Annex D – Risk concepts

Probability and severity scalesQualitative – 3 and 5 level scales are shown

SeverityCatastrophic Death Critical Permanent impairment

or life threateningSerious Medical interventionMinor No medical interventionNegligible Inconvenience or

temporary

31

Annex D – Risk concepts

Probability and severity scales

Probability – with verbal or numerical descriptors14971 other

Frequent >10-3 highly likelyProbable < 10-3 and >= 10-4 will occurOccasional < 10-4 and >=10-5 may occurRemote < 10-5 and >=10-6 possible but unlikelyImprobable < 10-6 very unlikely

32

Page 17: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 17

Annex D – Risk concepts

Scale issuesHow many levels?

3? 5? 10?

Levels are often ill defined especially probability

Often imprecise, yet precision is pretended

Tendency to be optimistic (if not cheat)

33

Annex D – Risk concepts

Matrix

Severity

Probability

Page 18: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 18

Annex D – Risk concepts

Matrix

Severity

Probability

Good (more or less)

Annex D – Risk concepts

Matrix

Severity

Probability

Bad (more or less)

Good (more or less)

Page 19: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 19

Annex D – Risk concepts

Matrix

Severity

Probability

Bad (more or less)

Good (more or less) Challenging!

Annex D – Risk concepts

Matrix

Severity

Probability

Bad (more or less)

Good (more or less) Challenging!

And the rest?

Page 20: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 20

Annex D – Risk concepts

There is no zone that is automatically acceptable or unacceptable

The manufacturer must have their own decision and sign off process

April 2010 39

Annex D – Risk concepts

Analysis of Risk: Are Current Methods Theoretically Sound?

Applying risk assessment may not give manufacturers the answers they think they are gettingNataly F. Youssef and William A. Hyman

http://www.mddionline.com/article/analysis-risk-are-current-methods-theoretically-sound

April 2010 40

Page 21: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 21

AnnexesRationaleOverviewIdentifying device characteristics associated with riskRisk conceptsExamples of hazardsRisk management planTechniquesIn vitro Biological hazardsResidual risk

41

Annex G- Risk management techniques

Preliminary hazard analysis (PHA)

early review of potential risks and their possible causation

early guidance on what will need to be controlled

April 2010 42

Page 22: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 22

Annex G- Risk management techniques

Fault tree analysis (FTA)

> define a bad event> identify what can lead to that event> identify what can lead to the things

that lead to the event> etc

April 2010 43

FTA

April 2010 44

Bad event #1

Cause #1 Cause #2 Cause #3

Cause (a) of

cause #1

Cause (b) of

cause #1

Page 23: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 23

Annex G- Risk management techniques

Failure Modes and Effects Analysis(FMEA)

> identify a failure mode of compoent, device, or user

> identify the effects of that failure mode

> perform risk assessment to determine if the effect requires action

April 2010 45

Annex G- Risk management techniques

Hazard and Operability Study(HAZOP)> similar to FMEA> emphasis on use of system

Hazard Analysis and Critical Control Points> similar to or uses many of the same

methods> emphasis on processes

(e.g. manufacturing)April 2010 46

Page 24: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 24

AnnexesRationaleOverviewIdentifying device characteristics associated with riskRisk conceptsExamples of hazardsRisk management planTechniquesIn vitro Biological hazardsResidual risk

47

Annex J- Residual risk

CommunicationAudienceMethodEffectiveness

April 2010 48

Page 25: FDA Medical Device Industry Coalitionfmdic.org/wp-content/uploads/2010/12/overview-risk.pdf · ISO 14971: Overview of the standard April 2, 2010 William Hyman, Sc.D. 1 FDA Medical

ISO 14971: Overview of the standard April 2, 2010

William Hyman, Sc.D. 25

April 2010 49

SUMMARY

Risk management is a good thing…even if there wasn’t an FDA

14971 is a well recognized guide to risk management methodologyBut…it is not a cook book, or a check list, or an alternative to conscientious effortThe objective is to use it thoughtfully as opposed to going through the motions to meet regulatory requirements

April 2010 50

Questions?Questions?